IGF Signaling Pathway as a Selective Target of Familial Breast Cancer Therapy

Author(s): Vivek Shukla, Xavier Coumoul, Athanassios Vassilopoulos, Chu-Xia Deng

Journal Name: Current Molecular Medicine

Volume 8 , Issue 8 , 2008

Become EABM
Become Reviewer
Call for Editor


Hereditary breast cancers affect women who have an increased risk of developing tumors because of a familial history. In most cases, they can be attributed to mutations in the breast cancer associated gene 1 and 2 (BRCA1 and BRCA2). Recent studies have demonstrated a link between the insulin-like growth factor (IGF) signaling pathway and familial breast cancer incidence. IGF and IGF receptors represent a family of biological growth factors and transducers, which have been involved in both physiological and pathological processes. It has been shown that BRCA1 regulates expression of several members of the IGF family. Here, we will examine our understanding of the functions of IGF/IGF-receptor signaling, the development of new inhibitors of this pathway and the related mechanisms of familial breast cancer formation.

Keywords: BRCA1, IGF/IGF-receptor, inhibitor, siRNA, mouse model

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2008
Published on: 01 March, 2012
Page: [727 - 740]
Pages: 14
DOI: 10.2174/156652408786733694
Price: $65

Article Metrics

PDF: 11